[1] Massarweh NN, El-Serag HB.Epidemiology of Hepatocellular Carcinoma and Intrahepatic holangiocarcinoma[J]. Cancer Control, 2017,24(3): 1145164509.
[2] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3] 夏永祥,张峰,李相成,等. 原发性肝癌10 966例外科治疗分析[J]. 中华外科杂志,2021,59(1):6-17.
[4] 邢人伟,殷平,聂寒秋,等. 超声引导下射频消融术与腹腔镜肝部分切除术治疗小肝癌的比较分析[J]. 肝胆胰外科杂志,2020,32(3):133-137.
[5] Liu W, Xiu N, Zhao J, et al.Enhanced therapeutic effect of transcatheter arterial chemoembolization combined with radioactive I-125 seed implantation on liver cancer[J]. Oncology Lett, 2020, 20(3): 2493-2498.
[6] 吴镜强. 125I放射性粒子植入治疗TACE抵抗肝癌的临床疗效[D]. 广州医科大学,2020.
[7] 颜克松. TACE联合125I粒子治疗肝细胞癌合并门脉癌栓疗效的Meta分析[D]. 甘肃中医药大学,2020.
[8] 任文君,王泽阳,黄欣,等. 肝动脉化疗栓塞术联合125I放射性粒子植入术与单独肝动脉化疗栓塞术治疗肝癌的meta分析[J]. 介入放射学杂志,2019,28(2):132-137.
[9] 朱楠,吕维富,张甜甜,等. 放射性125I粒子植入治疗原发性肝癌研究进展[J]. 中国介入影像与治疗学,2018,15(11):689-692.
[10] Chen K, Xia Y, Wang H, et al.Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial[J]. PLoS One, 2013, 8(2):e57397.
[11] 齐二朋,刘方义,谭水莲,等. 超声引导下放射性125I粒子植入治疗肝脏危险部位肿瘤疗效分析[J]. 中华肝胆外科杂志,2019,25(3):161-163.
[12] 苏伟力,齐二朋,高元瑾,等. 超声引导放射性粒子治疗复发性肝癌的疗效及安全性评价[J]. 中华医学超声杂志(电子版),2020,17(4):296-299.
[13] 杜思韵,付平,盖保东,等. 超声引导下经皮穿刺植入放射性125I粒子治疗腹部恶性肿瘤[J]. 中华医学超声杂志(电子版),2019,16(2):142-146.
[14] Zhang Y, Ding M, Chi JC, et al.The early evaluation of ultrasound-guided iodine-125 interstitial implants for high-risk hepatocellular carcinoma[J]. Brachytherapy, 2019, 18(5): 733-739.
[15] 何祥萌,许玉军,朱丽萍,等. 开放式磁共振实时透视引导125I放射性粒子治疗脑肿瘤的临床应用[J]. 介入放射学杂志,2019,28(11):1095-1099.
[16] 朱向玉,武乐斌,李成利. 介入性MR引导125I粒子源植入近距离治疗肿瘤的进展[J]. 医学影像学杂志,2007,(1):87-90.
[17] 林征宇,林军,陈少明,等. 1.5T MRI引导125I粒子组织间插植治疗恶性肿瘤的可行性[J]. 中国介入影像与治疗学,2011,8(1):5-9.
[18] 许玉军,柳明,何祥萌,等. 1.0T开放型磁共振引导经皮穿刺125I放射性粒子植入治疗晚期胰腺癌[J]. 山东大学学报(医学版),2017,55(2):21-25.
[19] Yao L, Cao Q, Wang J, et al.CT-Guided 125I Seed Interstitial Brachytherapy as a Salvage Treatment for Recurrent Spinal Metastases after External Beam Radiotherapy[J]. Biomed Res Int,2016, 2016: 8265907.
[20] Cao Q, Wang H, Meng N, et al.CT-guidance interstitial(125)I odine seed brachytherapy as a salvage therapy for recurrent spinal primary tumors[J]. Radiat Oncol, 2014, 9: 301.
[21] Yao L, Jiang Y, Jiang P, et al.CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy[J]. Brachytherapy, 2015, 14(5): 662-669.
[22] Wang JJ, Yuan HS, Li JN, et al.CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy[J]. Med Oncol, 2010, 27(2): 421-429.
[23] Jiang YL, Meng N, Wang JJ, et al.CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers[J]. Radiat Oncol, 2010, 5: 68.
[24] Jiang P, Liu C, Wang J, et al.Computed tomography (CT)-guided interstitial permanent implantation of (125)I seeds for refractory chest wall metastasis or recurrence[J]. Technol Cancer Res Treat, 2015, 14(1): 11-18.
[25] 郑树成,李玉柱,王洪峰,等. 螺旋CT引导下肿瘤组织间125I粒子植入用于肝癌的疗效分析[J]. 肝脏,2020,25(1):59-61.
[26] 李保国,郭志,王海涛,等. CT引导下放射性125I粒子植入治疗难治性肝转移癌的临床观察[J]. 临床肿瘤学杂志,2013, 18(8):713-717.
[27] Wang J, Chai S, Wang R, et al.Expert consensus on computed tomography-assisted three-dimensional-printed coplanar template guidance for interstitial permanent radioactive 125I seed implantation therapy[J]. J Cancer Res Ther, 2019, 15(7): 1430-1434.
[28] 高贞,张宏涛,王娟,等. 3D打印模板与徒手穿刺125I粒子植入治疗浅表转移癌剂量学对比分析[J]. 中华医学杂志,2019,(47):3694-3695.
[29] Han T, Yang X, Xu Y, et al.Therapeutic value of 3-D printing template-assisted 125I-seed implantation in the treatment of malignant liver tumors[J].Onco Targets Ther, 2017, 10: 3277-3283.
[30] Huang W, Lu J, Chen KM, et al.Preliminary application of 3D-printed coplanar template for iodine-125 seed implantation therapy in patients with advanced pancreatic cancer[J]. World J Gastroenterol, 2018, 24(46): 5280-5287. |
